Recently, DeHeng Hong Kong and Beijing offices assisted Hong Kong Pharma Digital Technology Holdings Limited to complete the listing on Nasdaq.

On October 31, 2024, Beijing Biostar Biopharmaceuticals Co., Ltd. (stock code: 02563.HK) completed its initial public offering (IPO) of H-shares and was listed on the Main Board of the Hong Kong Stock Exchange.

On October 25, 2024, Anhui Jinpeng Flavors & Fragrances Co., Ltd. was listed on the National Equities Exchange and Quotations (NEEQ) system, with stock code 874648.

Recently, DeHeng assisted ZhongZhou Water Holding Co., Ltd. in obtaining the non-objection letter from the Shanghai Stock Exchange for its application to privately issue corporate bonds of no more than RMB 1 billion, with th

Recently, a large central enterprise completed an equity exit transaction with a local state-owned enterprise, receiving full investment proceeds and returns.

Recently, DeHeng successfully handled the change of actual controller and controlling shareholder for a private fund manager under a provincial State-owned Assets Supervision and Administration Commission, which was approved